Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious medical conditions, ...
Marine Log

BOEM moves ahead on Gulf of America and Cook Inlet offshore lease sales

President Trump’s signing of the One Big Beautiful Bill Act marked the beginning of a new chapter for oil and gas development ...